TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants With Sustained Recovery
Endpoint domain: Mortality/survival
Primary endpoint: Body Image Self Esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Self Esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Estimation of fistula formation in three groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cholesterol and fractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glycated hemoglobin A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change in Cellulite Severity Scale (CSS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in User Interaction and Engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Zarit Burden Assessment Caregiver Strain instrument
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Quality of Life - 18 (QoL-18)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Brief Quality of Life - 8 (QoL-8)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cure at 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Adverse events related to antimicrobial therapy/vascular access complication
Endpoint domain: Adverse events/effects
Primary endpoint: Change of function of the masticatory muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AAT effect score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Distance of shuttle walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous glucose monitoring system (Percentage of time spent above 8mmol/l)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Monocyte subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Performance on motor task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reading Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language/Literacy Disorder Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Montreal Cognitive Assessment Test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Hospital Anxiety and Depression Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Pittsburgh Sleep Quality Index scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Critical threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with dose interruptions and dose reductions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Functional Brain Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in the gut Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ultrasound attenuation parameter (UAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Efficacy of T3D-959 on cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Efficacy of T3D-959 on function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and tolerability of T3D-959
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of CRS of any grade
Endpoint domain: Adverse events/effects
Primary endpoint: Molecular signature differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High Acceptability to Brensocatib Formulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in finger dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in uncarboxylated matrix Gla protein (ucMGP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in phylloquinone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in menaquinone-7 (MK-7) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Confirmation of Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye-tracking fixation point trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fundus examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: primary outcome measure
Endpoint domain: General outcomes
Primary endpoint: ROADS Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Clinical Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antitumor activity (Objective Response Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Insulin Sensitivity Score (ISS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence and intensity of Sore Throat Post Operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in acceptability of the SI-ROBOTICS system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in pain intensity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fatigue ratings
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in anxiety symptom ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in Vitiligo Area Scoring Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stenosis of coronary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term disease and death risk
Endpoint domain: Mortality/survival
Primary endpoint: Etiological detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in rTNSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of family planning counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Average Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Glucose Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Minimum Foot Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Foot Flat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Disabilities of the Arm, Shoulder, and Hand (DASH) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: single dose safety
Endpoint domain: Adverse events/effects
Primary endpoint: multiple dose safety
Endpoint domain: Adverse events/effects
Primary endpoint: Suppression of the hypothalamic-pituitary-adrenal axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants wearing the smart t-shirt for 8 hours per day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: dB SNR Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of empagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: association between cervical length and preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: anti-DNA glycoform measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic rate of Muscle MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterization of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of overall excellent CPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle mass perceived by participants
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Score of the QSQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: pH value of secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median percent change in focal seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BMI-for-age z-scores (BAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Immunoglobulin G (IgG) specific to SARS-COV-2 titer concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Onset of labour by 40 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Intra-Individual Variability (IIV) as measured by Cogstate Brief Battery (CBB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants receiving XR-naltrexone injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Concentration Versus Time Curve for the Last Measurable Concentration (AUClast) of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From the Time of Dosing Extrapolated to Infinity (AUC0-inf) of Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in expression of interleukin-4 (IL4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Annual rate of decline in Forced Vital Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Telemetry Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in MDS-UPDRS Part II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in severity of essential tremors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life, general
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life, caregiver-specific
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of study activity completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: risk of inhospital sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acneiform Rash Investigator's Global Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: EuroQol 5-Dimension 5-Level (EQ-5D-5L) Visual Analogue Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall satisfaction with stimulation mode
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clavien-Dindo grade III or greater
Endpoint domain: Adverse events/effects
Primary endpoint: Major flap dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants that underwent SPK transplant
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion of full course of ruxolitinib without cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombus-muscle signal-to-noise ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean antibody titer of anti-GD2 IgG1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: histological diagnosis of molar pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hCG undetectable in the urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma level of Pyronaridine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma level of Artesunate/dihydroartemisinin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients meeting RASS sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving ≥ 5% total body weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achieving ≥ 5% superiority margin for weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the health and disability Curve at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time to complete Trail Making B-A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stroop Color and Word score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Logical Memory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain-derived neurotrophic factor (BDNF) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Positive predictive values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical fit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hypogonadal Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Response rate to IL-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIV use or reintubation in 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increase in antibody levels post-vaccination (Euroimmun assay)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in antibody levels post-vaccination (Roche IgG assay)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in antibody levels post-vaccination (live virus neutralization)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cellular immunity markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients converting to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of post operative opioid consumption for the first 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Amount of radioactivity excreted in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative radioactivity excreted in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) from time zero extrapolated to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response rate (CR rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Plasma Concentration-Time Curve From Time Zero To Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defined dysynapsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence rates of selected safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in perceived cognitive difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Boston Bowel Prep Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SARS-CoV-2 detection via RT-PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Maximum tolerated dose (MTD) of vemurafenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative change in actual weekly PS volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of urine leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-minutes walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refusal Rate of Sales
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Blood Oxygen Level Dependent (BOLD) signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance in detecting EGFR T790M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Augmented Velocity Index (Avi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Successful Fits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Fit Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User Acceptance Percentage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: delirium-free days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: coma-free days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Central Sensitization Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of complete myocardial reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of correct sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct positioning of the device in the trachea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vital Signs And Physical Examination Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Adult Sensory Processing Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived weight stigmatization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sternocleidomastoid muscle normalized median frequency change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intradialytic hypotension episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean flow velocities in the left atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Caffeine Expectancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Assessment of Laparoscopic Skills (GOALS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total standing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PVSE total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change between active treatment and sham treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD negative rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Body Fat (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HADS (The Hospital Anxiety And Depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Patient-informed Most Bothersome Symptom (PI-MBS) Score at Week 24
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Quality of Life (QOL) as Measured by the 5 Level Euro Quality of Life 5 Dimensional Questionnaire (EQ-5D-5L) Score at Week 24
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Good Days From Baseline
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Clinically significant dyspnea - D-VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status